 | • レポートコード：MRC2102QY10510 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のペプチド抗生物質市場について種類別（リボソーム合成ペプチド抗生物質、非リボソーム合成ペプチド抗生物質）、用途別（製薬・医療、食品産業、商品、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ペプチド抗生物質市場の概要 ・世界の主要地域別ペプチド抗生物質市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のペプチド抗生物質市場規模2015-2026：種類別（リボソーム合成ペプチド抗生物質、非リボソーム合成ペプチド抗生物質） ・世界のペプチド抗生物質市場規模2015-2026：用途別（製薬・医療、食品産業、商品、その他） ・ペプチド抗生物質の米国市場規模2015-2020 ・ペプチド抗生物質のヨーロッパ市場規模2015-2020 ・ペプチド抗生物質の中国市場規模2015-2020 ・ペプチド抗生物質の日本市場規模2015-2020 ・ペプチド抗生物質の東南アジア市場規模2015-2020 ・ペプチド抗生物質のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ペプチド抗生物質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ペプチド抗生物質の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Peptide Antibiotics Market
The global Peptide Antibiotics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Peptide Antibiotics Scope and Market Size
The global Peptide Antibiotics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Peptide Antibiotics market is segmented into
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
Segment by Application, the Peptide Antibiotics market is segmented into
Pharma & Healthcare
Food Industry
Commodities
Other
The Peptide Antibiotics market is analysed and market size information is provided by regions (countries). Segment by Application, the Peptide Antibiotics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptide Antibiotics Market Share Analysis
Peptide Antibiotics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptide Antibiotics business, the date to enter into the Peptide Antibiotics market, Peptide Antibiotics product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation
1 Peptide Antibiotics Market Overview
1.1 Peptide Antibiotics Product Scope
1.2 Peptide Antibiotics Segment by Type
1.2.1 Global Peptide Antibiotics Sales by Type (2020-2026)
1.2.2 Ribosomal Synthesized Peptide Antibiotics
1.2.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Peptide Antibiotics Segment by Application
1.3.1 Global Peptide Antibiotics Sales Comparison by Application (2020-2026)
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 Peptide Antibiotics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peptide Antibiotics Sales Growth Rate (2015-2026)
1.4.2 Global Peptide Antibiotics Revenue and Growth Rate (2015-2026)
1.4.3 Global Peptide Antibiotics Price Trends (2015-2026)
2 Peptide Antibiotics Estimate and Forecast by Region
2.1 Global Peptide Antibiotics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peptide Antibiotics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peptide Antibiotics Sales Market Share by Region (2015-2020)
2.2.2 Global Peptide Antibiotics Revenue Market Share by Region (2015-2020)
2.3 Global Peptide Antibiotics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peptide Antibiotics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peptide Antibiotics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peptide Antibiotics Estimates and Projections (2015-2026)
2.4.2 Europe Peptide Antibiotics Estimates and Projections (2015-2026)
2.4.3 China Peptide Antibiotics Estimates and Projections (2015-2026)
2.4.4 Japan Peptide Antibiotics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peptide Antibiotics Estimates and Projections (2015-2026)
2.4.6 India Peptide Antibiotics Estimates and Projections (2015-2026)
3 Global Peptide Antibiotics Competition Landscape by Players
3.1 Global Top Peptide Antibiotics Players by Sales (2015-2020)
3.2 Global Top Peptide Antibiotics Players by Revenue (2015-2020)
3.3 Global Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Antibiotics as of 2019)
3.4 Global Peptide Antibiotics Average Price by Company (2015-2020)
3.5 Manufacturers Peptide Antibiotics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peptide Antibiotics Players (Opinion Leaders)
4 Global Peptide Antibiotics Market Size by Type
4.1 Global Peptide Antibiotics Historic Market Review by Type (2015-2020)
4.1.1 Global Peptide Antibiotics Sales Market Share by Type (2015-2020)
4.1.2 Global Peptide Antibiotics Revenue Market Share by Type (2015-2020)
4.1.3 Global Peptide Antibiotics Price by Type (2015-2020)
4.2 Global Peptide Antibiotics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peptide Antibiotics Sales Forecast by Type (2021-2026)
4.2.2 Global Peptide Antibiotics Revenue Forecast by Type (2021-2026)
4.2.3 Global Peptide Antibiotics Price Forecast by Type (2021-2026)
5 Global Peptide Antibiotics Market Size by Application
5.1 Global Peptide Antibiotics Historic Market Review by Application (2015-2020)
5.1.1 Global Peptide Antibiotics Sales Market Share by Application (2015-2020)
5.1.2 Global Peptide Antibiotics Revenue Market Share by Application (2015-2020)
5.1.3 Global Peptide Antibiotics Price by Application (2015-2020)
5.2 Global Peptide Antibiotics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peptide Antibiotics Sales Forecast by Application (2021-2026)
5.2.2 Global Peptide Antibiotics Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptide Antibiotics Price Forecast by Application (2021-2026)
6 United States Peptide Antibiotics Market Facts & Figures
6.1 United States Peptide Antibiotics Sales Market Share by Company (2015-2020)
6.2 United States Peptide Antibiotics Sales Market Share by Type (2015-2020)
6.3 United States Peptide Antibiotics Sales Market Share by Application (2015-2020)
7 Europe Peptide Antibiotics Market Facts & Figures
7.1 Europe Peptide Antibiotics Sales Market Share by Company (2015-2020)
7.2 Europe Peptide Antibiotics Sales Market Share by Type (2015-2020)
7.3 Europe Peptide Antibiotics Sales Market Share by Application (2015-2020)
8 China Peptide Antibiotics Market Facts & Figures
8.1 China Peptide Antibiotics Sales Market Share by Company (2015-2020)
8.2 China Peptide Antibiotics Sales Market Share by Type (2015-2020)
8.3 China Peptide Antibiotics Sales Market Share by Application (2015-2020)
9 Japan Peptide Antibiotics Market Facts & Figures
9.1 Japan Peptide Antibiotics Sales Market Share by Company (3015-3030)
9.2 Japan Peptide Antibiotics Sales Market Share by Type (2015-2020)
9.3 Japan Peptide Antibiotics Sales Market Share by Application (2015-2020)
10 Southeast Asia Peptide Antibiotics Market Facts & Figures
10.1 Southeast Asia Peptide Antibiotics Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Peptide Antibiotics Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Peptide Antibiotics Sales Market Share by Application (2015-2020)
11 India Peptide Antibiotics Market Facts & Figures
11.1 India Peptide Antibiotics Sales Market Share by Company (2015-2020)
11.2 India Peptide Antibiotics Sales Market Share by Type (2015-2020)
11.3 India Peptide Antibiotics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Peptide Antibiotics Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Peptide Antibiotics Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Peptide Antibiotics Products Offered
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Business Overview
12.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Peptide Antibiotics Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Corporation Information
12.4.2 Eli Lilly Business Overview
12.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly Peptide Antibiotics Products Offered
12.4.5 Eli Lilly Recent Development
12.5 Theravance
12.5.1 Theravance Corporation Information
12.5.2 Theravance Business Overview
12.5.3 Theravance Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Theravance Peptide Antibiotics Products Offered
12.5.5 Theravance Recent Development
12.6 Vicuron Pharmaceuticals
12.6.1 Vicuron Pharmaceuticals Corporation Information
12.6.2 Vicuron Pharmaceuticals Business Overview
12.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Products Offered
12.6.5 Vicuron Pharmaceuticals Recent Development
12.7 Savara Pharmaceuticals
12.7.1 Savara Pharmaceuticals Corporation Information
12.7.2 Savara Pharmaceuticals Business Overview
12.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Savara Pharmaceuticals Peptide Antibiotics Products Offered
12.7.5 Savara Pharmaceuticals Recent Development
12.8 AMP Therapeutics
12.8.1 AMP Therapeutics Corporation Information
12.8.2 AMP Therapeutics Business Overview
12.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AMP Therapeutics Peptide Antibiotics Products Offered
12.8.5 AMP Therapeutics Recent Development
12.9 Hospira
12.9.1 Hospira Corporation Information
12.9.2 Hospira Business Overview
12.9.3 Hospira Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hospira Peptide Antibiotics Products Offered
12.9.5 Hospira Recent Development
12.10 Kasten
12.10.1 Kasten Corporation Information
12.10.2 Kasten Business Overview
12.10.3 Kasten Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kasten Peptide Antibiotics Products Offered
12.10.5 Kasten Recent Development
12.11 Madam Therapeutics
12.11.1 Madam Therapeutics Corporation Information
12.11.2 Madam Therapeutics Business Overview
12.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Madam Therapeutics Peptide Antibiotics Products Offered
12.11.5 Madam Therapeutics Recent Development
12.12 Phosphagenics
12.12.1 Phosphagenics Corporation Information
12.12.2 Phosphagenics Business Overview
12.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Phosphagenics Peptide Antibiotics Products Offered
12.12.5 Phosphagenics Recent Development
12.13 Pacgen Life Science Corporation
12.13.1 Pacgen Life Science Corporation Corporation Information
12.13.2 Pacgen Life Science Corporation Business Overview
12.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pacgen Life Science Corporation Peptide Antibiotics Products Offered
12.13.5 Pacgen Life Science Corporation Recent Development
13 Peptide Antibiotics Manufacturing Cost Analysis
13.1 Peptide Antibiotics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peptide Antibiotics
13.4 Peptide Antibiotics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peptide Antibiotics Distributors List
14.3 Peptide Antibiotics Customers
15 Market Dynamics
15.1 Peptide Antibiotics Market Trends
15.2 Peptide Antibiotics Opportunities and Drivers
15.3 Peptide Antibiotics Market Challenges
15.4 Peptide Antibiotics Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Peptide Antibiotics Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Peptide Antibiotics Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Peptide Antibiotics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Peptide Antibiotics Sales (MT) by Region (2015-2020)
Table 5. Global Peptide Antibiotics Sales Market Share by Region (2015-2020)
Table 6. Global Peptide Antibiotics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Peptide Antibiotics Revenue Share by Region (2015-2020)
Table 8. Global Peptide Antibiotics Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Peptide Antibiotics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Peptide Antibiotics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Peptide Antibiotics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Peptide Antibiotics (MT) of Key Companies (2015-2020)
Table 13. Global Peptide Antibiotics Sales Share by Company (2015-2020)
Table 14. Global Peptide Antibiotics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Peptide Antibiotics Revenue Share by Company (2015-2020)
Table 16. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Antibiotics as of 2019)
Table 17. Global Peptide Antibiotics Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Peptide Antibiotics Manufacturing Sites and Area Served
Table 19. Manufacturers Peptide Antibiotics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Peptide Antibiotics Players
Table 22. Global Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 23. Global Peptide Antibiotics Sales Share by Type (2015-2020)
Table 24. Global Peptide Antibiotics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Peptide Antibiotics Price (MT) by Type (2015-2020)
Table 26. Global Peptide Antibiotics Sales Share by Type (2021-2026)
Table 27. Global Peptide Antibiotics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Peptide Antibiotics Revenue Share by Type (2021-2026)
Table 29. Global Peptide Antibiotics Price (MT) by Type (2021-2026)
Table 30. Global Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 31. Global Peptide Antibiotics Sales Share by Application (2015-2020)
Table 32. Global Peptide Antibiotics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Peptide Antibiotics Price (MT) by Application (2015-2020)
Table 34. Global Peptide Antibiotics Sales (MT) by Application (2021-2026)
Table 35. Global Peptide Antibiotics Sales Share by Application (2021-2026)
Table 36. Global Peptide Antibiotics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Peptide Antibiotics Revenue Share by Application (2021-2026)
Table 38. Global Peptide Antibiotics Price (MT) by Application (2021-2026)
Table 39. United States Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 40. United States Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 41. United States Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 42. United States Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 43. United States Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 44. United States Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 45. Europe Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 46. Europe Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 47. Europe Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 48. Europe Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 49. Europe Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 50. Europe Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 51. China Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 52. China Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 53. China Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 54. China Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 55. China Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 56. China Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 57. Japan Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 58. Japan Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 59. Japan Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 60. Japan Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 61. Japan Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 62. Japan Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 69. India Peptide Antibiotics Sales (MT) by Company (2015-2020)
Table 70. India Peptide Antibiotics Sales Market Share by Company (2015-2020)
Table 71. India Peptide Antibiotics Sales (MT) by Type (2015-2020)
Table 72. India Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 73. India Peptide Antibiotics Sales (MT) by Application (2015-2020)
Table 74. India Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Pfizer Peptide Antibiotics Product
Table 79. Pfizer Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Novartis Peptide Antibiotics Product
Table 84. Novartis Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Peptide Antibiotics Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Eli Lilly Peptide Antibiotics Product
Table 94. Eli Lilly Recent Development
Table 95. Theravance Corporation Information
Table 96. Theravance Description and Business Overview
Table 97. Theravance Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Theravance Peptide Antibiotics Product
Table 99. Theravance Recent Development
Table 100. Vicuron Pharmaceuticals Corporation Information
Table 101. Vicuron Pharmaceuticals Description and Business Overview
Table 102. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Vicuron Pharmaceuticals Peptide Antibiotics Product
Table 104. Vicuron Pharmaceuticals Recent Development
Table 105. Savara Pharmaceuticals Corporation Information
Table 106. Savara Pharmaceuticals Description and Business Overview
Table 107. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Savara Pharmaceuticals Peptide Antibiotics Product
Table 109. Savara Pharmaceuticals Recent Development
Table 110. AMP Therapeutics Corporation Information
Table 111. AMP Therapeutics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. AMP Therapeutics Description and Business Overview
Table 113. AMP Therapeutics Peptide Antibiotics Product
Table 114. AMP Therapeutics Recent Development
Table 115. Hospira Corporation Information
Table 116. Hospira Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Hospira Description and Business Overview
Table 118. Hospira Peptide Antibiotics Product
Table 119. Hospira Recent Development
Table 120. Kasten Corporation Information
Table 121. Kasten Description and Business Overview
Table 122. Kasten Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Kasten Peptide Antibiotics Product
Table 124. Kasten Recent Development
Table 125. Madam Therapeutics Corporation Information
Table 126. Madam Therapeutics Description and Business Overview
Table 127. Madam Therapeutics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Madam Therapeutics Peptide Antibiotics Product
Table 129. Madam Therapeutics Recent Development
Table 130. Phosphagenics Corporation Information
Table 131. Phosphagenics Description and Business Overview
Table 132. Phosphagenics Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Phosphagenics Peptide Antibiotics Product
Table 134. Phosphagenics Recent Development
Table 135. Pacgen Life Science Corporation Corporation Information
Table 136. Pacgen Life Science Corporation Description and Business Overview
Table 137. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Pacgen Life Science Corporation Peptide Antibiotics Product
Table 139. Pacgen Life Science Corporation Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Peptide Antibiotics Distributors List
Table 143. Peptide Antibiotics Customers List
Table 144. Peptide Antibiotics Market Key Trends
Table 145. Peptide Antibiotics Key Opportunities and Drivers
Table 146. Peptide Antibiotics Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Antibiotics Product Picture
Figure 2. Global Peptide Antibiotics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Peptide Antibiotics Market Share by Application in 2020 & 2026
Figure 6. Pharma & Healthcare Examples
Figure 7. Food Industry Examples
Figure 8. Commodities Examples
Figure 9. Other Examples
Figure 10. Global Peptide Antibiotics Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Peptide Antibiotics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Peptide Antibiotics Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Peptide Antibiotics Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Peptide Antibiotics Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Peptide Antibiotics Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Peptide Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Peptide Antibiotics Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Peptide Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Peptide Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Peptide Antibiotics Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Peptide Antibiotics Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Peptide Antibiotics Players Market Share by Revenue in Peptide Antibiotics 2015 & 2019
Figure 28. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Peptide Antibiotics Revenue Share by Type (2015-2020)
Figure 30. Global Peptide Antibiotics Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Peptide Antibiotics Revenue Share by Application (2015-2020)
Figure 32. Global Peptide Antibiotics Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Peptide Antibiotics Sales Market Share by Type in 2019
Figure 34. United States Peptide Antibiotics Sales Market Share by Type in 2019
Figure 35. Europe Peptide Antibiotics Sales Market Share by Company in 2019
Figure 36. Europe Peptide Antibiotics Sales Market Share by Type in 2019
Figure 37. Europe Peptide Antibiotics Sales Market Share by Application in 2019
Figure 38. China Peptide Antibiotics Sales Market Share by Company in 2019
Figure 39. China Peptide Antibiotics Sales Market Share by Type in 2019
Figure 40. China Peptide Antibiotics Sales Market Share by Application in 2019
Figure 41. Japan Peptide Antibiotics Sales Market Share by Company in 2019
Figure 42. Japan Peptide Antibiotics Sales Market Share by Type in 2019
Figure 43. Japan Peptide Antibiotics Sales Market Share by Application in 2019
Figure 44. Southeast Asia Peptide Antibiotics Sales Market Share by Company in 2019
Figure 45. Southeast Asia Peptide Antibiotics Sales Market Share by Type in 2019
Figure 46. Southeast Asia Peptide Antibiotics Sales Market Share by Application in 2019
Figure 47. India Peptide Antibiotics Sales Market Share by Company in 2019
Figure 48. India Peptide Antibiotics Sales Market Share by Type in 2019
Figure 49. India Peptide Antibiotics Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Peptide Antibiotics
Figure 52. Manufacturing Process Analysis of Peptide Antibiotics
Figure 53. Peptide Antibiotics Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
ナトリウム利尿ペプチドの世界市場レポート2020 Market Analysis and Insights: Global Natriuretic Peptide Market The global Natriuretic Peptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Natriuretic Peptide Scope and Market Size The global Natriuretic Peptide mar…- ペプチドシンセサイザーの世界市場レポート2020 Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis. Peptides are used to prepare epitope-specific antibodies, map antibody epitopes and enzyme binding sites and to design novel enzymes, drugs and vaccines. Peptide synthesis is …
- グルカゴン様ペプチド-1（GLP-1）アゴニストの世界市場レポート2020 Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia. Un…
- ペプチド合成の世界市場レポート2020 Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress to…
- 抗菌ペプチドの世界市場レポート2020 Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, bro…